🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

American Vanguard's Unit Buys Syngenta's Products In Mexico

Published 08/24/2017, 06:34 AM
Updated 07/09/2023, 06:31 AM
US500
-
SYENF
-
KRA
-
AVD
-
PKX
-
CC
-

American Vanguard’s (NYSE:AVD) fully-owned unit AMVAC Mexico Srl has completed the purchase of specific herbicide and fungicide products sold in Mexico from Syngenta AG (SIX:SYNN). Financial terms of the deal were not divulged.

The products acquired by AMVAC Mexico includes seven branded selective herbicides for sugar cane and eight contact fungicide brands. These products have generated sales in the range of $8-$10 million in the recent past.

The divestment of these products results from Mexico's antitrust commission, COFECE’s resolution (dated as of Apr 7, 2017) associated with the acquisition of Syngenta by China National Chemical Corporation (ChemChina).

American Vanguard noted that the addition of these products complements and strengthens its herbicide and fungicide offerings. AMVAC Mexico has been operating in the Mexican crop protection market for more than two decades and is also expanding its foothold in this market.

American Vanguard’s shares gained 18.1% over the past year, outperforming the 0.6% decline of the industry it belongs to.


American Vanguard saw its profits jump around 33% year over year in second-quarter 2017, helped by its cost control initiatives. Sales also rose in the quarter, partly driven by strong demand for cotton products.

The company saw healthy gains in international sales and growth in its granular soil insecticide products in the quarter on the back of higher demand in domestic corn, peanuts and sugar crops. This more than offset weather-related declines in soil fumigant sales and pricing pressure in corn herbicides.

American Vanguard, in its second-quarter call, said that its outlook for the remainder of 2017 is positive. The company noted that significant increase cotton acreage in the U.S. should provide additional sales of its Bidrin foliar insecticide and Folex harvest defoliant in the second half of 2017. American Vanguard also sees modest international growth and a rebound in its soil fumigant business.

Moreover, the company expects continued demand for its Dibrom mosquito adulticide. American Vanguard remains focused on managing working capital and operational costs and investing in technology innovation for future growth.

American Vanguard currently carries a Zacks Rank #3 (Hold).

Stocks to Consider

Better-placed companies in the basic materials space include The Chemours Company (NYSE:CC) , Kraton Corporation (NYSE:KRA) and POSCO (NYSE:PKX) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Chemours has an expected long-term earnings growth of 15.5%.

Kraton has an expected earnings growth of 7.2% for the current year.

POSCO has an expected long-term earnings growth of 5%.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>



Chemours Company (The) (CC): Free Stock Analysis Report

Kraton Corporation (KRA): Free Stock Analysis Report

American Vanguard Corporation (AVD): Free Stock Analysis Report

POSCO (PKX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.